Your browser doesn't support javascript.
loading
Reply to letter that comments on 'Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma: Feasibility, acute toxicity and evidence for efficacy'.
Pompe, R S; von Bueren, A O; Mynarek, M; von Hoff, K; Rutkowski, S.
Afiliación
  • Pompe RS; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Germany.
  • von Bueren AO; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Germany; Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, University Medical Center, Goettingen, Germany.
  • Mynarek M; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Germany.
  • von Hoff K; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Germany.
  • Rutkowski S; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Germany. Electronic address: s.rutkowski@uke.de.
Eur J Cancer ; 56: 181-182, 2016 Mar.
Article en En | MEDLINE | ID: mdl-26774521
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Cerebelosas / Meduloblastoma Límite: Female / Humans / Male Idioma: En Revista: Eur J Cancer Año: 2016 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Cerebelosas / Meduloblastoma Límite: Female / Humans / Male Idioma: En Revista: Eur J Cancer Año: 2016 Tipo del documento: Article País de afiliación: Alemania